Trial intelligence / Profile preview

Preprocedural vitamin K in acenocoumarol-anticoagulated patients

2018-002291-41Phase 4Completed

Sponsor
Hospital Gelderse Vallei
Start
Aug 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of phytomenadione, sponsored by Hospital Gelderse Vallei. Primary endpoints: Prothrombin (factor II) activity at day of invasive procedure and Factor VII activity at day of invasive procedure. Started Aug 2018; status: completed.

02

Drugs

phytomenadione

Beyond the preview

Go deeper on 2018-002291-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002291-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call